Cargando…

Pharmacological mechanism of roflumilast in the treatment of asthma–COPD overlap

Asthma–COPD overlap (ACO) is a type of incomplete obstructive airway disease that has a high incidence and mortality. Nevertheless, there is currently no clear definition of ACO and no effective intervention. The newly discovered phosphodiesterase-4 inhibitor, roflumilast, has shown initial efficacy...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Xiaoli, Chen, Yuqing, Fan, Liyu, Ye, Jiaqi, Fan, Junsheng, Xu, Xinjie, You, Danming, Liu, Sihan, Chen, Xin, Luo, Peng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2018
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6078181/ https://www.ncbi.nlm.nih.gov/pubmed/30122895 http://dx.doi.org/10.2147/DDDT.S165161

Ejemplares similares

The efficacy and safety of alectinib in the treatment of ALK+ NSCLC: a systematic review and meta-analysis
por: Fan, Junsheng, et al.
Publicado: (2018)

Roflumilast in COPD: a Brazilian perspective
por: Stirbulov, Roberto, et al.
Publicado: (2015)

Phenotype of Asthma-COPD Overlap in COPD and Severe Asthma Cohorts
por: Joo, Hyonsoo, et al.
Publicado: (2022)

Vulnerable COPD patients with comorbidities: the role of roflumilast
por: Lipari, Melissa, et al.
Publicado: (2014)

Efficacy and Safety of Roflumilast in Korean Patients with COPD
por: Lee, Jae Seung, et al.
Publicado: (2016)

Importance of fractional exhaled nitric oxide in the differentiation of asthma–COPD overlap syndrome, asthma, and COPD
por: Chen, Feng-jia, et al.
Publicado: (2016)

Heterogeneity of asthma and COPD overlap
por: Kim, Min-Hye, et al.
Publicado: (2018)

New therapeutic options in the management of COPD – focus on roflumilast
por: Antoniu, Sabina Antonela
Publicado: (2011)

Roflumilast: a review of its use in the treatment of COPD
por: Wedzicha, Jadwiga A, et al.
Publicado: (2016)

Does roflumilast induce phagocytic activity in COPD patients?
por: Ghosh, Baishakhi, et al.
Publicado: (2015)

Sputum cell count: biomarkers in the differentiation of asthma, COPD and asthma–COPD overlap
por: Gao, Jie, et al.
Publicado: (2017)

The Value of Impulse Oscillometric Parameters and Quantitative HRCT Parameters in Differentiating Asthma–COPD Overlap from COPD
por: Lu, Dongzhu, et al.
Publicado: (2021)

Fatigue, Depression, and Anxiety in Patients with COPD, Asthma and Asthma-COPD Overlap
por: Homętowska, Henryka, et al.
Publicado: (2022)

Characteristics of Asthma-COPD Overlap According to Various Criteria
por: Jung, Ji Ye
Publicado: (2021)

Heterogeneity of asthma–COPD overlap syndrome
por: Joo, Hyonsoo, et al.
Publicado: (2017)

Roflumilast: first phosphodiesterase 4 inhibitor approved for treatment of COPD
por: Giembycz, Mark A, et al.
Publicado: (2010)

The Value of Inflammatory Biomarkers in Differentiating Asthma–COPD Overlap from COPD
por: Li, Meng, et al.
Publicado: (2020)

Health characteristics of patients with asthma, COPD and asthma–COPD overlap in the NHANES database
por: Llanos, Jean-Pierre, et al.
Publicado: (2018)

Coronary heart disease and heart failure in asthma, COPD and asthma-COPD overlap
por: Ingebrigtsen, Truls Sylvan, et al.
Publicado: (2020)

Mucus Plugs and Small Airway Dysfunction in Asthma, COPD, and Asthma-COPD Overlap
por: Tamura, Kanami, et al.
Publicado: (2022)

Adherence to roflumilast under dose-escalation strategy in Korean patients with COPD
por: Park, Tai Sun, et al.
Publicado: (2019)

The clinical features of the overlap between COPD and asthma
por: Hardin, Megan, et al.
Publicado: (2011)

Inflammatory biomarkers in asthma-COPD overlap syndrome
por: Kobayashi, Seiichi, et al.
Publicado: (2016)

Smoking history and emphysema in asthma–COPD overlap
por: Kurashima, Kazuyoshi, et al.
Publicado: (2017)

Asthma–COPD overlap: identification and optimal treatment
por: Cosío, Borja G., et al.
Publicado: (2018)

Genetic Associations and Architecture of Asthma-COPD Overlap
por: John, Catherine, et al.
Publicado: (2022)

Risk of Malignancy in Patients with Asthma-COPD Overlap Compared to Patients with COPD without Asthma
por: Bonnesen, Barbara, et al.
Publicado: (2022)

COPD assessment test and severity of airflow limitation in patients with asthma, COPD, and asthma–COPD overlap syndrome
por: Kurashima, Kazuyoshi, et al.
Publicado: (2016)

Biomarker-based detection of asthma–COPD overlap syndrome in COPD populations
por: Tamada, Tsutomu, et al.
Publicado: (2015)

Physiological and morphological differences of airways between COPD and asthma–COPD overlap
por: Karayama, Masato, et al.
Publicado: (2019)

ACO (Asthma–COPD Overlap) Is Independent from COPD: The Case Against
por: Calverley, Peter M. A., et al.
Publicado: (2021)

Impact of asthma, chronic obstructive pulmonary disease (COPD), and asthma-COPD overlap on the prognosis of coronavirus disease 2019
por: Shin, Eunyong, et al.
Publicado: (2022)

Comparison of pulmonary function in patients with COPD, asthma-COPD overlap syndrome, and asthma with airflow limitation
por: Kitaguchi, Yoshiaki, et al.
Publicado: (2016)

Differential DAMP release was observed in the sputum of COPD, asthma and asthma-COPD overlap (ACO) patients
por: Huang, Xiaolin, et al.
Publicado: (2019)

Clinical Indicators for Asthma-COPD Overlap: A Systematic Review and Meta-Analysis
por: Peng, Junjie, et al.
Publicado: (2022)

PDE4 inhibitors as potential therapeutic agents in the treatment of COPD-focus on roflumilast
por: Boswell-Smith, Victoria, et al.
Publicado: (2007)

Glucocorticoid Receptor α Mediates Roflumilast’s Ability to Restore Dexamethasone Sensitivity in COPD
por: Reddy, Aravind T, et al.
Publicado: (2020)

Clinical and inflammatory characteristics of Asthma-COPD overlap in workers with occupational asthma
por: Ojanguren, Iñigo, et al.
Publicado: (2018)

The overlap phenotype: the (missing) link between asthma and COPD
por: Piras, Barbara, et al.
Publicado: (2012)

Characterization of sputum biomarkers for asthma–COPD overlap syndrome
por: Gao, Jing, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_o3l0tg49ifjqjtsafi4de92asi